Divestment
Cardior
Cardior develops RNA-based therapies for cardiovascular diseases, aiming to halt or reverse heart failure progression.
Key Facts
- Sector
Life Sciences
- Country
Germany
- Fund
LSP 5
- Entry
2017
- Exit
2024
Website
Responsible Partner
News
Do You Want to Know More?
We are eager to explore how we can achieve great things together.